2022年至2031年美国邮购药品市场将以18.66%的复合年增长率增长,达到1718.8303亿美元

Publication Month : Oct 2023

  • Report Code : TIPRE00030083
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 114
Inquire Before Buy

PRICING

$3000

$2400

美国邮购药品市场规模预计将从2022年的4372.862万美元增长到2030年的1718.8303万美元;预计 2022 年至 2030 年复合年增长率为 18.66%。

分析师观点

美国邮购药品市场分析揭示了促进其增长的关键因素;其中包括慢性病发病率的增加以及满足不同医疗保健需求的邮购药房服务的采用激增。此外,人工智能 (AI) 与零售药店的集成预计将成为 2022 年至 2030 年市场的新趋势。根据药物类型,美国邮购药房市场分为非处方药和处方药。处方药细分市场在 2022 年占据了更大的市场份额,预计该细分市场在 2022 年至 2030 年期间的复合年增长率将更高。美国邮购药品市场按产品细分为皮肤护理产品、抗糖尿病药物、心血管药物、血压药物、哮喘管理产品、感冒药和保健品。流感药物、止痛药、抗酸剂等。皮肤护理产品领域在 2022 年占据最大的市场份额,心血管药物领域预计在 2022 年至 2030 年期间复合年增长率最高。根据订购方式,美国邮购药房市场分为在线商店和药房应用程序。预计在线商店细分市场将在 2022 年至 2030 年期间占据最大市场份额。

邮购药房可以轻松使用计算机管理药品订购和补充或智能手机。药物可以通过邮购药房订购,价格较便宜,并且可以包含在健康计划中。保险公司可以以较低的成本直接从药品制造商处大量购买药品。

市场洞察

慢性病发病率上升推动美国邮购药品市场增长

慢性病,如糖尿病、心血管疾病、自身免疫性疾病和各种癌症类型是全世界死亡的主要原因。根据美国慢性病主任协会 2022 年报告,近 40% 的美国成年人患有多种慢性病 (MCC)。此外,国家卫生委员会的报告显示,慢性病占美国总医疗费用的 75% 以上。根据美国年度医疗保健支出总额,心脏病、癌症、精神障碍和肺部疾病位列五种最昂贵的健康疾病之列。同样,糖尿病是危及生命的慢性疾病之一,无法进行功能性治愈。所有类型的糖尿病都可能导致不同身体部位的并发症,并引发过早死亡的总体风险。根据美国疾病控制与预防中心(CDC)发布的报告,美国每年共有3730万人(即美国人口的11.3%)患有糖尿病,其中850万人(即成年人的23.0%)患有糖尿病。 )未确诊病例和 2870 万(2850 万成人)确诊病例。慢性病患者坚持用药可以提供更好的健康结果,同时减少住院次数和费用。大约 24% 的哮喘恶化是由于不坚持吸入皮质类固醇引起的。在美国,人们已经做出了许多尝试来提高药物依从性和改善患者护理。各种保险公司提供经济激励措施,鼓励客户通过邮购药房配药,这对患者来说更便宜。邮购药房服务通常用于购买治疗高胆固醇、哮喘、高血压、糖尿病和抑郁症等慢性疾病的药物。通过这种药房模式,顾客可以收到 90 天的药品,而不必每月重新配药。因此,除了慢性病发病率不断上升、用药不依从之外,人口老龄化以及相对于传统方法的便利性也推动了美国邮购药品市场的增长。

战略洞察

未来趋势

人工智能融合零售药店中的人工智能

随着消费者继续优先考虑自己的健康和保健,零售药店热衷于采用新技术来简化流程并提高消费者便利性。他们专注于通过将人工智能工具集成到运营中来改善服务、降低成本并优化库存可用性。人工智能集成提供了竞争优势,可以指导患者完成专业处方配药流程,从而提高购买的便利性。 2019 年 4 月,亚马逊推出了 Amazon Alexa 的升级版,能够执行符合 HIPAA 的医疗保健服务,例如存储血糖测量值和提供处方配送更新。

许多零售药房巨头正在与人工智能公司合作改善患者护理。人工智能整合的趋势正在连锁药店中加速发展。 2023 年 4 月,Express Scripts 推出了新的“ClearCareRx”模型,该模型旨在增加获得负担得起的药物的机会,并提高透明度和可预测性。此外,快捷药方还与医疗保健提供者和健康计划客户密切合作,提供咨询选项,为消费者提供负担得起的药品。此外,Express Scripts 还提供了更广泛的预防性处方药物清单,通过增加健康储蓄账户缴款,这些药物可以享受折扣、较低保费和免赔额的全面保障。因此,邮购药房和人工智能公司之间的合作可能会在未来几年使美国邮购药房市场受益。

报告细分和范围

基于药物类型的见解

基于药品类型方面,美国邮购药房市场分为非处方药和处方药。处方药细分市场在 2022 年占据更大的市场份额,预计 2020-2030 年该细分市场的复合年增长率将达到 19.11%。邮购药房根据医疗专业人员提供的真实门诊处方配药。他们需要处方才能配发癌症药物、心血管药物和糖尿病药物等药物。癌症、心血管疾病和糖尿病等慢性疾病的患病率不断上升,以及孤儿疾病病例的不断增加,可能有利于美国处方药邮购药房市场。此外,蓬勃发展的研发活动和高额医疗保健支出对该领域的市场增长做出了显着贡献。美国需要的主要处方药是肿瘤药物,其次是呼吸系统药物,例如抗炎药、肺液体替代药、减充血剂、生物制剂和吸入皮质类固醇。调脂剂在主要处方药中占据第三位。

许多网上药房平台都提供处方药配送服务。由于电子商务平台和互联网服务的覆盖范围不断扩大,对邮购药品的需求不断增加。美国许多网上药店提供送货上门服务,并参与处方药的配发。 2023 年 7 月,CVS Caremark 和 GoodRx 推出了 Caremark Cost Saver,这是一种处方药折扣解决方案,旨在帮助广大 CVS Caremark 会员降低成本并改善体验。

< span>基于产品的洞察

根据产品,美国邮购药品市场分为皮肤护理产品、抗糖尿病药物、心血管药物、血液药物压力药物、哮喘管理产品、感冒药和药物流感药物、止痛药、抗酸剂等。皮肤护理产品细分市场在2022年占据最大市场份额,心血管药物细分市场预计2020-2030年的复合年增长率最高为22.89%。对面霜、防晒霜和润肤露的需求不断增长,以及电子商务平台的日益普及,预计将有利于预测期内美国邮购药品市场的发展。这些药店提供的皮肤护理产品的价格比当地药店更优惠。此外,还通过这些平台提供多种皮肤护理产品,包括防晒霜、抗衰老霜、润肤露和亮肤霜。护肤产品的获取更加便捷,交易和产品成本更低,更加便利,并且具有最佳的匿名性。根据麦肯锡公司发表的一篇文章截至2023年5月,美妆细分市场的电商业务从2015年到2022年几乎翻了两番,份额超过20%。在过去的几年里,人们对皮肤护理产品的好处的认识不断提高,从而增加了他们的需求。此外,天然和有机护肤品近年来大受欢迎,使其成为化妆品和健康行业的领先部分。因此,美国不断进步的化妆品和保健行业有利于皮肤护理领域邮购药品市场的增长。

在美国,慢性心脏病的流行由于久坐的生活方式一直在稳步上升,导致心血管疾病的高发病率。此外,越来越多的被诊断患有心血管疾病的老年人口正在推动美国各地对治疗这些疾病的药物的需求。据美国心力衰竭协会称,2020年,美国报告称,由于缺乏护理协调,两次或多次入院的心力衰竭患者数量有所增加。这种激增归因于缺乏持续的护理提供者、缺乏后续护理以及无法在家跟踪血压和体重的手段。美国心力衰竭协会 (AHA) 还透露,药物是再入院的主要原因。因此,相当大的目标人群正在对心血管药物领域邮购药房市场的增长产生积极影响。抗缺血药、抗心绞痛药和强心苷等药物通过在线处方药房服务广泛分销。通过邮购药房订购治疗心血管疾病的处方药非常方便,并且有助于提高用药依从性。研究表明,使用邮购药物服务的心脏病患者的依从率为 84.7%,而当地药房用户的依从率为 76.9%。如此高的依从率可归因于邮购药房提供的 90 天处方补充、送货上门服务和 24/7 药剂师支持。例如,接受胆固醇控制治疗的 Kaiser Permanente 患者在前 3-15 个月内取得了更好的控制,并通过邮购药房获得了他汀类药物处方。

订购方式-基于洞察

从订购模式来看,美国邮购药房市场分为在线商店和药房应用。在线商店细分市场在 2022 年占据更大的市场份额,预计 2020-2030 年该细分市场的复合年增长率将达到 19.08%。美国许多制药公司正在采用在线药房模式来发展医疗保健领域的业务。 Lloyads Pharmacy 和 HeathWareHouse.com 等药店通过其在美国的在线商店提供送货上门服务。网上药店让消费者无需到实体药店就可以购买药品,为消费者提供了更大的便利,全国各地对该商店模式的需求不断增加。全国各地的医生现在更喜欢电子处方,以便患者能够轻松获得药物。人们可以轻松地将电子处方上传到电子药房网站上,在线订购药物,并将药物送到所需地点。

高度发达的IT基础设施,智能手机的增加高速互联网在城市和农村地区的采用和渗透提振了网上药店市场。各国采取的越来越多的举措,以实惠的价格提供处方药,也推动了对在线药店的需求。

美国邮购药房市场(按药物类型) – 2022年和2030年

国家分析

美国邮购药房市场预计将从 2022 年的 437.2862 亿美元增至 2030 年的 1718.8303 亿美元。预计 2022 年至 2030 年该市场的复合年增长率为 18.66%。 邮购药房配药参考门诊处方。这些类型的药房专注于分发维持处方,导致美国门诊处方销售的大部分。与社区药房相比,此类药房为患者提供在线订购补充药物的服务,具有送货上门的便利性和广泛的供应链。对于患者来说,邮购药房的费用通常较低,但对于健康计划提供者来说却很昂贵。根据2021年《美国预防医学杂志》发表的文章,邮购药店在美国门诊处方市场的份额从1989年的6%飙升至2013年的15.2%。近年来药店有所减少; 2019年,该比例下降至门诊处方的9.5%。

社区药房之间日益激烈的竞争以及与邮购药房相关的利好政策预计将推动药房的增长未来几年美国邮购药品市场。亚马逊等提供邮购服务的公司对零售药店构成了越来越大的威胁。过去十年,美国邮购药店已经占据主导地位并不断发展,目前每年邮寄数十亿张处方的产品。

根据 CDC 获得的数据,每年开出约 38 亿张处方。在这些处方中,大约 50% 在时间、剂量、频率和持续时间方面存在误解。美国退伍军人事务部 (VA) 开展有利于退伍军人及其家庭成员的计划。它提供药房福利管理服务,约占通过 VA 配药并使用该国高度自动化药房的集中邮购药房 (CMOP) 网络通过邮购发送的门诊处方的 80%。沃尔格林、CVS 和亚马逊等公司正在通过推出新服务将其电子商务业务转变为数字交付平台。例如,2020 年 11 月,亚马逊推出了亚马逊药房,这是一项在线和移动处方药订购和履行服务。在此平台上,客户可以添加保险详细信息、选择付款方式并管理处方。

该报告介绍了美国邮购药品市场的领先参与者。其中包括 CVS Health Corp、沃尔玛 Inc、Envirotainer AB、Able Freight Services LLC、Deutsche Post AG、GeniusRx、Geisinger Health、Cornerstone Health Solutions LLC、Humana Inc、Ridgeway Pharmacy LLC 和 The Cigna Group。< /p>

    2023 年 7 月,CVS Caremark 和 GoodRx 推出了 Caremark Cost Saver,以帮助 CVS Caremark 客户降低自付费用处方费用。 CVS Caremark 合格会员将自动获得 GoodRx 处方定价,从而能够以更低的成本购买仿制药。 2021 年 10 月,GeniusRx 推出了 GeniusClinic 和 GeniusIQ,为消费者提供透明、透明的处方药获取渠道。 GeniusIQ 是一个机器学习平台,用于补充和为非急性和生活方式疾病开出新药。

公司简介

  • CVS 健康公司   
  • 沃尔玛公司          
  • Envirotainer AB       
  • Able Freight Services LLC    
  • 德国邮政股份公司    < li>GeniusRx     
  • 盖辛格健康      
  • 基石健康解决方案有限责任公司           
  • Humana Inc          
  • Ridgeway Pharmacy LLC     
  • Cigna 集团
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the US Mail-Order Pharmacy across the globe?

Key factors that are driving the growth of this market are increasing incidences of chronic diseases and increasing adoption of mail order pharmacy services for specific healthcare needs to boost the market growth for the US Mail-Order Pharmacy over the years.

Which drug type segment leads the US Mail-Order Pharmacy?

Prescription medicine segment held the largest share of the market in the US mail-order pharmacy and held the largest market share in 2022.

What is US Mail-Order Pharmacy?

Mail-order pharmacy makes it easy to manage medication ordering and refill using a computer or a smartphone. Medications are ordered by mail order pharmacy less expensive and are operated through health plan. The insurer can buy medications in large quantities directly from drug manufacturers to lower costs.

What is the market CAGR value of US Mail-Order Pharmacy during forecast period?

The CAGR value of the US Mail-Order Pharmacy during the forecasted period of 2023-2028 is 18.66%.

Which are the top companies that hold the market share in US Mail-Order Pharmacy?

CVS Health Corp and GeniusRx are the top two companies that hold huge market shares in the US mail-order pharmacy.

Which product segment held the largest share in the US Mail-Order Pharmacy?

The dermal care segment dominated the US mail-order pharmacy and held the largest market share in 2022.

Who are the key players in the US Mail-Order Pharmacy?

The US mail-order pharmacy majorly consists of the players such CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Cornerstone Health Solutions LLC, Humana Inc, Ridgeway Pharmacy LLC, and The Cigna Group, and among others. .

The List of Companies - US Mail Order Pharmacy Market 

  1. CVS Health Corp                  
  2. Walmart Inc          
  3. Envirotainer AB    
  4. Able Freight Services LLC                  
  5. Deutsche Post AG               
  6. GeniusRx                
  7. Geisinger Health                  
  8. Cornerstone Health Solutions LLC                 
  9. Humana Inc           
  10. Ridgeway Pharmacy LLC    
  11. The Cigna Group

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports